Do Renal Tumor Characteristics Affect the Number of Hemostatic Agents Used During Partial Nephrectomy?/Bobrek Tumoru Ozellikleri Parsiyel Nefrektomi Sirasinda Kullanilan Hemostatik Ajan Sayisini Etkiler mi?

• Published in: Journal of urological surgery Vol. 6; no. 3; p. 225
• Main Authors: Kisa, Erdem, Keskin, Mehmet Zeynel, Sahin, Hilal, Yucel, Cem, Yalcin, Mehmet Yigit, Cakmak, Ozgur, Ilbey, Yusuf Ozlem
• Format: Journal Article
• Language: English
• Published: Galenos Yayinevi Tic. Ltd 01-09-2019
• Subjects: Cancer; Cellulose; Fluorine compounds; Ischemia; Medical research; Polysaccharides; Polytetrafluoroethylene; Surgery; Tumors
• DOI: 10.4274/jus.galenos.2019.2712
• EISSN: 2148-9580

Objective: The aim of this study was to investigate the use and types of hemostatic agents (HAs) used during partial nephrectomy (PN) and the relationship of the number of these agents used during surgery with tumor size, RENAL nephrometry score (NS), peroperative ischemia time, and postoperative pathology results. Materials and Methods: Records of patients, who had undergone PN in our clinic due to renal mass between January 2013 and February 2019, were retrospectively reviewed. Our study included 71 patients who were administered one or more HAs during PN. Demographic characteristics, operative data, and pathological results of patients, who were administered one or more HAs during PN, were recorded. Results: Cellulose-based agents and polytetrafluoroethylene pledgets were the most frequently used HAs (78.8% and 38%, respectively). The patients were divided into two groups according to tumor size (0-4 cm and larger than 4 cm tumors), RENAL NS (low and intermediate-high score), ischemia time (0-20 min and longer than 20 min), and tumor pathology result (benign and malignant tumor), and the number of HAs used in each group was compared. When the groups were compared separately in terms of number of HAs used, no statistically significant difference was found between the groups (p=0.323, p=0.183, p=0.618, and p=0.131, respectively). Conclusion: HAs are frequently used in our clinic to achieve hemostasis. There was no statistically significant difference in the number of HAs used between the groups. Keywords: Renal mass, Partial nephrectomy, Hemostatic agents Amac: Calismamizin amaci parsiyel nefrektomi (PN) operasyonu sirasinda hemostatik ajan (HA) kullaniminin yayginligi ve bu kullanilan HA sayisinin hastalarin tumor boyutu, RENAL nefrometri skoru (NS), iskemi zamani ve tumor patoloji sonucu ile iliskisini arastirmaktir. Geree ve Yontem: Klinigimizde renal kitle nedeniyle Ocak 2013 - Subat 2019 tarihleri arasinda PN operasyonu geciren hastalarin kayitlari tarandi. PN sirasinda HA kullanilan 71 hasta calismaya dahil edildi. PN sirasinda HA kullanilan hastalarin demografik ozellikleri, operasyon bilgileri, patolojik sonuclari ve komplikasyonlari kaydedildi. Bulgular: Seluloz bazli ajanlar (%78,8) ve politetrafloroetilen pledgets (%38) PN sirasinda en sik kullanilan HA'lardir. Tumor boyutu (0-4 cm ve 4 cm'den buyuk tumorler), RENAL NS (dusuk puan-orta puan-yuksek puan), iskemi suresi (0-20 dk ve 20 dk'dan uzun iskemi suresi) ve tumor patoloji sonucu (benign tumor-malign tumor), kendi icerisinde gruplara ayrildi ve gruplar icerisinde kullanilan HA sayilari karsilastirildi. Kullanilan HA sayisi acisindan gruplar ayri ayri karsilastirildiginda, gruplar arasinda istatistiksel anlamli fark saptanmamistir (p=0,323, p=0,183, p=0,618, p=0,131 sirasiyla). Sonuc: HA'lar PN sirasinda hemostaz asamasinda klinigimizde cok sik kullanilmaktadir. Calisma gruplari arasinda, PN sirasinda kullanilan HA sayisi acisindan istatistiksel fark saptanmamistir. Anahtar Kelimeler: Renal kitle, Parsiyel nefrektomi, Hemostatik ajanlar